1

Pharmacotherapy : a pathophysiologic approach

Favoris Imprimer
Livre

DiPiro, Joseph T. / Yee, Gary C / Talbert, Robert L. / Wells, Barbara G. / Posey, L. Michael / Matzke, Gary R.

10th edition

McGraw-Hill Education

2017

xxxiii, 2474 p. : ill.

9781259587481

Anglais

Section 1 : Foundation issues
1. Health literacy and medication use -- 2. Cultural competency -- 3. Medication safety principles and practices -- 4. Clinical pharmacokinetics and pharmacodynamics -- 5. Pharmacogenetics -- 6. Pediatrics -- 7. Geriatrics -- 8. Palliative care -- 9. Clinical toxicology -- 10. Clinical management of potential bioterrorism-related conditions
Section 2 : Cardiovascular disorders
11. Cardiovascular testing -- 12. Cardiac arrest -- 13. Hypertension -- 14. Chronic heart failuare -- 15. Acute decompensated heart disease -- 17. Acute coronary syndromes -- 18. The arrhythmias -- 19. Venous thromboembolism -- 20. Stroke -- 21. Dyslipidemia -- 22. Peripheral arterial disease -- 23. Use of vasopressors and inotropes in the pharmacotherapy of shock -- 24. Hypovolemic shock -- 25. Introduction to pulmonary function testing
Section 3 : Respiratory disorders
26. Asthma -- 27. Chronic obst4ructive pulmonary disease -- 28. Pulmonary arterial hypertension -- 29. Cystic fibrosis -- 30. Drug-induced pulmonary diseases
Section 4 : Gastrointestinal disorders
31. Evaluation of the gastrointestinal tract -- 32. Gastroesophageal reflux disease -- 33. Peptic ulcer disease and related disorders -- 34. Inflammatory bowel disease -- 35. Nausea and vomiting -- 36. Diarrhea, constipation, and irritable bowel syndrome -- 37. Portal hypertension and cirrhosis -- 38. Drug-induced liver disease -- 39. Pancreatitis -- 40. Viral hepatitis -- 41. Celiac disease
Section 5 : Renal disorders
42. Evaluation of kidney of kidney function -- 43. Acute kidney injury -- 44. Chronic kidney disease -- 45. Hemodialysis and peritoneal dialysis -- 46. Drug-induced kidney disease -- 47. Glomerulonephritis -- 48. Drug therapy individualization for patients with chronic kidney disease -- 49. Disorders of sodium and water homeostasis -- 50. Disorders of calcium and phosphorus homeostais -- 51. Disorders of potassium and magnesium homeostasis -- 52. Acid-base disorders
Section 6 : Neurologic disorders
53. Evaluation of neurologic illness -- 54. Alzheimer disease -- 55. Multiple sclerosis -- 56. Epilepsy -- 57. Status epilepticus -- 58. Acute management of the brain injury patient -- 59. Parkinson disease -- 60. Pain management -- 61. Headache disorders
Section 7 : Psychiatric disorders
62. Assessment of psychiatric disorders -- 63. Attention deficit/hyperactivity disorder -- 64. Eating disorders -- 65. Substance-related disorders I : overview and depressants, stimulants, and hallucinogens -- 66. Substance-related disorders II : alcohol, nicotine and caffeine -- 67. Schizophrenia -- 68. Major depressive disorder -- 69. Bipolar disorder -- 70. Anxiety disorders : generalized anxiety, panic, and social anxiety disorders -- 71. Posttraumatic stress disorder and obsessive-copulsive disorder -- 72. Sleep-wake disorders -- 73. Disorders associated with intellectual disabilities
Section 8 : Endocrinologic disorders
74. Diabetes mellitus -- 75. Thyroid disorders -- 76. Adrenal gland disorders -- 77. Pituitary gland disorders
Section 9 : Gynecologic and obstetric disorders
78. Pregnancy and lactation : therapeutic considerations -- 79. Contraception -- 80. Menstruation-related disorders -- 81. Endometriosis -- 82. Hormone therapy in woman
Section 10 : Urologic disorders
83. Erectile dysfunction -- 84. Benign prostatic hyperplasia -- 85. Urinary incontinence
Section 11 : Immunologic disorders
86. Function and evaluation of the immune system -- 87. Systemic lupus erythematosus -- 88. Drug allergy -- 89. Solid-organ transplantation
Section 12 : Rheumatologic disorders
90. Osteoarthritis -- 91. Rheumatoid arthritis -- 92. Osteoporosis and osteomalacia -- 93. Gout and hyperuricemia
Section 13 : Ophthalmic and otolaryngological disorders
94. Glaucoma -- 95. Allergic rhinitis
Section 14 : Dermatologic disorders
96. Acne vulgaris -- 97. Psoriasis -- 98. Atopic dermatitis -- 99. Dermatologic drug reactions and common skin conditions
Section 15 : Hermatologic disorders
100. Anemia -- 101. Coagulation disorders -- 102. Sickle cell disease -- 103. Drug-induced hematologic disorders
Section 16 : Infectious diseases
104. Laboratory tests to direct antimicrobial -- 105. Antimicrobial regimen selection -- 106. Central nervous system infections -- 107. Lower respiratory tract infections -- 108. Upper respiratory tract infections -- 109. Influenza -- 110. Skin and soft-tissue infections -- 111. Infective endocarditis -- 112. Tuberculosis -- 113. Gastrointestinal infections and enterotoxigenic poisonings -- 114. Intra-abdominal infections -- 115. Parasitic diseases -- 116. Urinary tract infections and prostatitis -- 117. Sexually transmitted diseases -- 118. Bone and joint infections -- 119. Sepsis and septic shock -- 120. Superficial fungal infections -- 121. Invasive fungal infections -- 122. Infections in immunocompromised -- 123. Antimicrobial prophylaxis in surgery -- 124. Travel health -- 125. Vaccines and immunoglobulins -- 126. Human immunodeficiency virus infection
Section 17 : Oncologic disorders
127. Cancer treatment and chemotherapy -- 128. Breast cancer -- 129. Lung cancer -- 130. Colorectal cancer -- 131. Prostate cancer -- 132. Lymphomas -- 133. Ovarian cancer -- 134. Acute leukemias -- 135. Chronic leukemias -- 136. Multiple myeloma -- 137. Myelodysplastic syndromes -- 138. Renal cell carcinoma -- 139. Melanoma -- 140. Hematopoietic stem cell transplantation
Section 18 : Nuritional disorders
141. Assessment of nutrition status and nutrition requirements -- 142. Parental nutrition -- 143. Enteral nutrition -- 144. Obesity

Pharmacotherapy: A Pathophysiologic Approach is written to help readers advance the quality of patient care through evidence-based medication therapy derived from sound pharmacotherapeutic principles. The scope of this trusted classic goes beyond drug indications and dosages to include the initial selection, proper administration, and monitoring of drugs. Readers will find everything they need to provide safe, effective drug therapy across the full range of therapeutic categories.
This edition is enriched by more than 300 expert contributors, and every chapter has been revised and updated to reflect the latest in evidence-based information and recommendations. Important features such as Key Concepts at the beginning of each chapter, Clinical Presentation tables that summarize disease signs and symptoms, and Clinical Controversies boxes that examine the complicated issues faced by students and clinicians in providing drug therapy make this text an essential learning tool for students, patient-focused pharmacists, and other health care providers.

Physiopathologie / Chimiothérapie

QV 77 D596p 2017


Exemplaires

Nbre d'exemplaires : 1
Cote Localisation
1 QV 77 D596p 2017 Bibliothèque Rivière-des-Prairies [disponible]